Yoko Mizutani Selected Research

Yoko Mizutani Research Topics

Disease

13	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2023 - 02/2008
3	Pain (Aches) 04/2023 - 06/2007
3	Neoplasms (Cancer) 05/2017 - 02/2013
2	Skin Diseases (Skin Disease) 11/2020 - 08/2015
2	Dermatitis 08/2020 - 01/2020
2	Inflammation (Inflammations) 08/2020 - 02/2008
2	Pyoderma Gangrenosum 01/2017 - 06/2007
2	Ulcerative Colitis 02/2008 - 06/2007
1	Arthritis (Polyarthritis) 04/2023
1	Pruritus (Itching) 04/2023
1	Snoring 03/2023
1	VEXAS syndrome 01/2022
1	Impetigo (Impetigo Contagiosa) 03/2020
1	Granuloma 01/2020
1	Porokeratosis (Palmoplantar Porokeratosis) 11/2017
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 05/2017
1	Fever (Fevers) 05/2017
1	Leukocytosis (Pleocytosis) 05/2017
1	Acne Vulgaris 01/2017
1	Hidradenitis Suppurativa 01/2017
1	Bullous Pemphigoid (Pemphigoid) 01/2017
1	Epidermolysis Bullosa Pruriginosa 11/2016
1	Melanoma (Melanoma, Malignant) 10/2014
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 09/2014
1	Basal Cell Carcinoma (Rodent Ulcer) 06/2014
1	Atopic Dermatitis (Atopic Eczema) 03/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2013
1	Anaphylaxis (Anaphylactic Shock) 11/2011
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2008
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 02/2008
1	Osteoporosis 02/2008
1	Brain Infarction 02/2008
1	Hypertension (High Blood Pressure) 02/2008
1	Infections 01/2008
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2007
1	Skin Ulcer 06/2007
1	Ulcer 06/2007
1	Rheumatoid Arthritis 06/2007

Drug/Important Bio-Agent (IBA)

4	brodalumabIBA 04/2023 - 09/2022
3	EnzymesIBA 01/2022 - 10/2014
2	Interleukin-17 (Interleukin 17)IBA 03/2023 - 08/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2016 - 02/2008
2	Prednisolone (Predate)FDA LinkGeneric 01/2015 - 06/2007
2	Proteins (Proteins, Gene)FDA Link 02/2013 - 11/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2008 - 06/2007
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	UbiquitinIBA 01/2022
1	CytokinesIBA 08/2020
1	Messenger RNA (mRNA)IBA 08/2020
1	Imiquimod (Aldara)FDA LinkGeneric 08/2020
1	Interleukin-23 Subunit p19IBA 08/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 08/2020
1	Certolizumab Pegol FDA Link 07/2020
1	CollagenIBA 01/2020
1	LigandsIBA 11/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2017
1	C-Reactive ProteinIBA 05/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2017
1	AutoantibodiesIBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	KalininIBA 01/2017
1	Sphingosine-1-Phosphate ReceptorsIBA 10/2014
1	ErbB Receptors (EGF Receptor)IBA 10/2014
1	A-Form DNA (A-DNA)IBA 10/2014
1	sphingosine kinaseIBA 10/2014
1	Cisplatin (Platino)FDA LinkGeneric 10/2014
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2014
1	Antineoplastic Agents (Antineoplastics)IBA 10/2014
1	Fingolimod Hydrochloride (FTY720)FDA Link 10/2014
1	Minocycline (Cyclops)FDA LinkGeneric 09/2014
1	Microfilament Proteins (Actin Binding Proteins)IBA 06/2014
1	CeramidesIBA 03/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2014
1	InterferonsIBA 03/2014
1	SeptinsIBA 02/2013
1	AllergensIBA 11/2011
1	royal jellyIBA 11/2011
1	Etretinate FDA Link 02/2008
1	Complement System Proteins (Complement)IBA 01/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2007
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2007

Therapy/Procedure

9	Blood Component Removal (Apheresis) 11/2020 - 06/2007
5	Therapeutics 04/2023 - 06/2007
1	Aftercare (After-Treatment) 04/2023
1	Oral Administration 01/2015
1	Drug Therapy (Chemotherapy) 10/2014